China National Medicines Corp Ltd (600511) — Cash Flow-to-Debt Ratio
China National Medicines Corp Ltd (600511) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-540.00 Million could theoretically repay 0% of its total liabilities (CN¥15.19 Billion) in one year. See China National Medicines Corp Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China National Medicines Corp Ltd Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for China National Medicines Corp Ltd across 24 annual periods. For the full cash flow conversion analysis, see 600511 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for China National Medicines Corp Ltd (2001–2024)
Year-by-year debt coverage analysis for China National Medicines Corp Ltd. Check China National Medicines Corp Ltd (600511) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥1.66 Billion | CN¥15.95 Billion | ▼ -43.1% |
| 2023 | 0.18x | CN¥2.73 Billion | CN¥14.92 Billion | ▲ +4.9% |
| 2022 | 0.17x | CN¥2.40 Billion | CN¥13.75 Billion | ▲ +16.8% |
| 2021 | 0.15x | CN¥1.96 Billion | CN¥13.12 Billion | ▲ +35.4% |
| 2020 | 0.11x | CN¥1.30 Billion | CN¥11.81 Billion | ▼ -25.3% |
| 2019 | 0.15x | CN¥1.78 Billion | CN¥12.03 Billion | ▲ +63.9% |
| 2018 | 0.09x | CN¥981.65 Million | CN¥10.90 Billion | ▼ -10.2% |
| 2017 | 0.10x | CN¥1.07 Billion | CN¥10.71 Billion | ▼ -42.6% |
| 2016 | 0.17x | CN¥591.25 Million | CN¥3.38 Billion | ▲ +20.7% |
| 2015 | 0.14x | CN¥440.29 Million | CN¥3.04 Billion | ▲ +95.5% |
| 2014 | 0.07x | CN¥218.94 Million | CN¥2.96 Billion | ▲ +15.1% |
| 2013 | 0.06x | CN¥185.56 Million | CN¥2.88 Billion | ▼ -6.9% |
| 2012 | 0.07x | CN¥185.87 Million | CN¥2.69 Billion | ▲ +137.6% |
| 2011 | -0.18x | CN¥-370.56 Million | CN¥2.02 Billion | ▼ -218.2% |
| 2010 | 0.16x | CN¥318.21 Million | CN¥2.05 Billion | ▲ +3.0% |
| 2009 | 0.15x | CN¥255.18 Million | CN¥1.69 Billion | ▼ -21.7% |
| 2008 | 0.19x | CN¥217.10 Million | CN¥1.13 Billion | ▲ +197.7% |
| 2007 | 0.06x | CN¥79.48 Million | CN¥1.23 Billion | ▼ -59.0% |
| 2006 | 0.16x | CN¥121.50 Million | CN¥771.05 Million | ▲ +29.8% |
| 2005 | 0.12x | CN¥92.20 Million | CN¥759.27 Million | ▲ +74.0% |
| 2004 | 0.07x | CN¥49.18 Million | CN¥704.48 Million | ▲ +8123.0% |
| 2003 | 0.00x | CN¥526.15K | CN¥619.80 Million | ▼ -97.7% |
| 2002 | 0.04x | CN¥15.19 Million | CN¥408.75 Million | ▲ +194.8% |
| 2001 | -0.04x | CN¥-11.80 Million | CN¥300.99 Million | — |